At the 2013 AICPA Healthcare Industry Conference, PYA Principal David McMillan and Senior Manager Chris Wilson recently explored the “new normal” of meaningful use as compliance and strategic standards in new care/reimbursement-model development.
In “Meaningful Use: Beyond Stage I,” McMillan and Wilson reviewed major changes in the Stage 2 Final Rule, and the move from a world of attestation and implementation to one with access to big data; the latest forms of advanced and actionable data analytics; increased transparency; and other downstream effects. They demonstrated how meaningful use creates an increased compliance and auditing risk; becomes a new platform for implementing regulatory efforts such as the Physician Quality Reporting System; and establishes a de facto standard in new care/reimbursement-model development, such as clinically integrated networks and ACOs.
View the presentation below.
If you’d like more information or to request a speaker on the above topic, contact the experts listed below at PYA, (800) 270-9629.
WE ARE REQUIRED BY IRS CIRCULAR 230 TO INFORM YOU THAT THE FOLLOWING DISCUSSION WAS NOT INTENDED OR WRITTEN TO BE USED, AND IT CANNOT BE USED, NOR RELIED UPON, BY ANY TAXPAYER FOR THE PURPOSE OF AVOIDING ANY PENALTIES THAT MAY BE IMPOSED UNDER FEDERAL TAX LAW. THE ADVICE WAS WRITTEN TO SUPPORT THE PROMOTION OR MARKETING OF THE TRANSACTIONS OR MATTERS ADDRESSED IN THE DISCUSSION. EACH TAXPAYER SHOULD SEEK ADVICE BASED ON ITS PARTICULAR CIRCUMSTANCES FROM AN INDEPENDENT TAX ADVISOR.